Skip to content

ALAB · Astera Labs

2 filings

10-K

ALAB 10-K Annual Reports

Astera Labs - 2 annual reports

Filing record · 2024–202610-K210-Q88-K23

2025
Astera Labs Annual Report, Year Ended Dec 31, 2025
Astera Labs, Inc. (ALAB) demonstrated significant financial performance for the year ending December 31, 2025, with revenue soaring to $852.5 million, a substantial 115% increase from the prior year. This robust growth was driven by strong demand across its product lines, particularly Aries, Scorpio, and Taurus, alongside improved average selling prices. The company achieved a net income of $219.1 million, a dramatic turnaround from the net loss of $83.4 million in 2024, signaling strong operational improvements and market traction. Despite a slight decrease in gross margin to 75.7% due to a shift in product mix towards hardware modules, the company effectively managed operating expenses, which decreased by 7% year-over-year primarily due to a significant reduction in non-cash stock-based compensation. Astera Labs continues to invest heavily in research and development, with expenses increasing by 51% to support innovation in its Intelligent Connectivity Platform for cloud and AI infrastructure. The company's strong cash position and positive operating cash flow provide a solid foundation for continued growth and investment in its core technologies.
Feb 20, 2026
2024
Astera Labs Annual Report, Year Ended Dec 31, 2024
Astera Labs (ALAB) reported a transformative 2024 in its first full year as a public company after its March 2024 IPO. Revenue rose 242% to $396.3 million from $115.8 million, driven by a 217% increase in unit shipments, primarily of its Aries PCIe/CXL Smart DSP Retimers, and a richer product mix of hardware modules. Gross margin expanded 750 basis points to 76.4%, helped by lower inventory write-downs, and the company generated $136.7 million in operating cash flow. GAAP results remained loss-making, with a net loss of $83.4 million and an operating margin of -29.3%, largely because of $234.6 million in stock-based compensation, much of it tied to RSUs whose liquidity condition was satisfied by the IPO. On a non-GAAP basis, the company posted operating income of $119.6 million (30.2% margin) and net income of $143.3 million. The balance sheet is strong, with $914.3 million in cash, cash equivalents, and marketable securities after the IPO raised $672.2 million in net proceeds. Concentration is the central risk: the top three end customers accounted for approximately 80% of 2024 revenue, with Customer A alone at 36%, and TSMC is the sole source for integrated circuits. Taiwan (68% of revenue) and China (18%) are also significant exposures given trade restrictions. The company also disclosed material weaknesses in internal control over financial reporting, covering risk assessment, segregation of duties, and IT general controls, which remained unremediated at year-end, and its disclosure controls were concluded to be ineffective. Investors should weigh strong growth and margins against customer concentration, geopolitical exposure, control remediation, and heavy dilution from equity awards.
Feb 14, 2025